ECCO2017: EUROPEAN CANCER CONGRESS
From Evidence to Practice in Multidisciplinary Cancer Care
ECCO2017 is the European Cancer Congress where you will discover which new treatments are of value to your patients and applicable to your daily practice.
Established in 1981, the ECCO Congress is the only truly multidisciplinary meeting addressing all tumour types. ECCO congresses are unique, clinically oriented, multidisciplinary meetings with direct impact on clinical practice. The theme for the 19th edition is ‘From evidence to practice in multidisciplinary cancer care’.
At ECCO2017, you will:
- Discover which clinical trial results will truly change practice - and how they might be made affordable
With a focus on new data from phase III and real-world studies, ECCO2017 will provide a platform for critical evaluation and debate among a multidisciplinary audience. This will help you decide what will genuinely impact the treatment and care of your patients. Sessions will also discuss the challenge of rising costs of new treatments and how to deal with it.
- Learn how to manage challenging cases
ECCO2017 will be a truly multidisciplinary congress in which challenging cases—be they of a clinical, ethical, economic or regulatory nature—will be discussed. These discussions will reflect real challenges faced on a daily basis.
- Update your knowledge
The very latest scientific information from a multidisciplinary perspective will be given prime attention at ECCO2017. The congress will undoubtedly update and expand your knowledge to help you improve the way you carry out daily practice and care for you patients.
See what ECCO2017 has to offer take a look at our programme.
At ECCO2017, the focus is on the patient situation and this is from a multidisciplinary perspective. “If you work in the cancer community, then you should attend ECCO2017.” These are the words of Professor Peter Naredi, ECCO President, in his presidential address video.